Katarzyna Stencel

Neoadjuvant and Adjuvant Immunotherapy in Non-Small Cell Lung Cancer—Clinical Trials Experience

P. Krawczyk, R. Ramlau, I. Chmielewska, 2021, Cancers.

Long-Term Response to Afatinib in Lung Adenocarcinoma Harboring Compound Uncommon EGFR Mutations: Case Report

Katarzyna Stencel, 2021, Biomedical Journal of Scientific & Technical Research.

Molecular targeted therapy of patients with non-small-cell lung cancer

R. Ramlau, Katarzyna Stencel, D. Świniuch, 2019 .

Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations.

P. Krawczyk, J. Milanowski, R. Ramlau, 2017, Oncology letters.

Impact of copy number variant and single nucleotide polymorphism of the programmed death-ligand 1 gene, programmed death-ligand 1 protein expression and therapy regimens on overall survival in a large group of Caucasian patients with non-small cell lung carcinoma

P. Krawczyk, J. Milanowski, R. Ramlau, 2021, Oncology letters.

The role of diagnostics and treatment — lung cancer with ALK rearrangement

R. Ramlau, Katarzyna Stencel, R. Langfort, 2021 .

Predictors of EGFR mutation and factors associated with clinical tumor stage at diagnosis: Experience of the INSIGHT study in Poland.

P. Krawczyk, J. Milanowski, W. Olszewski, 2017, Oncology letters.

Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma

R. Ramlau, Katarzyna Stencel, Agnieszka Rybarczyk-Kasiuchnicz, 2021, International journal of molecular sciences.

Non-Small-Cell Lung Cancer: New Rare Targets—New Targeted Therapies—State of The Art and Future Directions

J. Milanowski, R. Ramlau, I. Chmielewska, 2021, Cancers.

Molecular alterations of driver genes in non-small cell lung cancer: from diagnostics to targeted therapy

Katarzyna Stencel, K. Kowalska, P. Kurzawa, 2023, EXCLI journal.